Evidence-Based
Backed by peer-reviewed research with cultural provenance and ChemPath™ + BioPath™ validation.
- TK validation engine
- Clinical tiering workflows
- Bias-aware scoring models
ChemPath™ · BioPath™
Cross-kingdom OS × Bias-aware evidence engine
Predicting Cross-Kingdom Therapeutics,Before They Reach the Lab.
NeuroBotanica is the world's first predictive systems biology platform for botanical drug discovery. We don't just catalog molecules; we map their path from ancestral wisdom to FDA compliance across cannabis, marine, fungal, and plant polysaccharide domains—the operating system for cross-kingdom therapeutics.
Studies Parsed
505+
Peer-reviewed + ethnobotanical corpus
Terpene Lift
49.8%
Accuracy boost over legacy tooling
Edge Latency
<10s
Cloudflare Workers global average
Nevada pilot intake · Q1
Two dispensary + lab slots remain for February.
Includes budtender enablement, Workers edge deployment, and evidence packets delivered in under four weeks.
Average onboarding timeline · 4 weeks
Email for pilot briefingGuideStar · PlatinumCloudflare ImpactStripe NonprofitGuideStar · PlatinumCloudflare ImpactStripe Nonprofit
AI-Powered
GenomePath™ inference models tuned on cannabis-specific corpora and cross-kingdom embeddings.
- Cloudflare Workers edge lattice
- Federated learning ready
GenomePath™
Comprehensive
RegPath™ keeps terpene, cannabinoid, and polysaccharide dimers in one cockpit with regulatory telemetry.
- Budtender tablet mode
- POS telemetry ingestion
- Regulatory snapshots
RegPath™
Cloak & Quill Research
501(c)(3) nonprofit stewarding NeuroBotanica for public benefit and open scientific access.
- Public-benefit stewardship
- Nonprofit research oversight
- Open evidence distribution to partners
Public benefit charter
Cross-Kingdom Intelligence
Synergy Beyond Boundaries
True therapeutic breakthroughs happen at the intersection of kingdoms. NeuroBotanica's inference engine predicts high-value dimeric combinations across four distinct domains.
- Cannabis (The Foundation)
Dimeric cannabinoids, terpene synergy, and 16 neuropsychiatric conditions.
Live · 505+ indexed studies- Marine Polysaccharides
Fucoidan and carrageenan for immunomodulation and oncology support.
Coming Q2 2026- Fungal Therapeutics
Beta-glucans and hericenones for neuroprotection and immune enhancement.
In development- Plant Polysaccharides
Galactomannans for glycemic control and gut health.
In development
Powered by OmniPath™
The Infrastructure of Compliance
Discovery is only the first step. Powered by OmniPath™, our proprietary trade-secret engines automate the journey from molecular identification to regulatory submission.
Evidence-Based
ChemPath™ + BioPath™ execute TK validation, CoA checks, and cultural provenance scoring.
AI-Powered
GenomePath™ inference blends Morgan fingerprints with multilingual embeddings at the edge.
Comprehensive
RegPath™ unifies terpene, cannabinoid, and polysaccharide dimers with regulatory telemetry.
Cloak & Quill Research
Cloak & Quill Research — a 501(c)(3) nonprofit stewarding NeuroBotanica for public benefit.
GenomePath™ AIBridging Ancient Wisdom & Modern Genomics
The vocabulary of Traditional Knowledge and the language of modern genomics have never spoken the same dialect—until now.
- 98.11% accuracy linking TK intents to genomic targets (e.g., TRPV1 downregulation).
- Bias-aware and built to route 70% of commercial value to Indigenous stakeholders.
- Hybrid AI combining Morgan ECFP4 fingerprints with multilingual text embeddings.
3A
7F
12
C8
0E
5D
1B
9C
2F
AA
44
6B
ECFP4
FusionTRPV1 Downshift
“Cooling breath” intents spanning Mapuche + Yawanawá pharmacopeia
CB2 Analgesic Arc
Philippines + Yucatán chronic pain rituals clustered via multilingual embeddings
Neuroimmune Shield
Marine polysaccharide rites for post-operative recovery with beta-glucan co-signals
Coming Q2 2026
Specialized Therapeutic Layers
Announcing PsychePath™ and SereniPath™ to extend NeuroBotanica's operating system into mental wellness and cross-cultural care.
PsychePath™
Psychological therapeutics addressing mental health care disparities.
SereniPath™
Cross-cultural wellness and anxiety frameworks with equity guardrails.
2026 Platform Roadmap
Q1 2026 (Now)
- Nevada dispensary pilot live
Q2 2026 – Specialized Therapeutics
- PsychePath™ + SereniPath™ integrations
- Enterprise API beta for NeuroBotanica Discovery endpoints
Q3 2026
- Cross-kingdom synergy engines live
- Geographic expansion into California
Validation Journey
From manuscript to deployment in four luminous steps.
Scrollytelling timeline pairs copper root systems with living data; ideal for Cloudflare Pages cinematic reveals.
Stage 01
Ingest & Normalize
Upload manuscripts, terpene panels, and TK metadata for harmonization.
11s ingestion median
Stage 02
Edge Inference
Workers multi-region lattice predicts viable dimers and terpene deltas.
235ms edge median
Stage 03
Bias-Aware Review
Human-in-the-loop review with cultural equity scoring and audit logs.
92% faster than manual
Stage 04
Pilot & Deploy
Stripe-backed retainers, budtender tablet rollout, and compliance packet.
4-week MVP pilots
Cannabis Intelligence
Nevada-ready terpene insight cockpit.
Heatmaps, terpene gauges, and compliance radar unify dispensary POS exhaust with NeuroBotanica inference. Motion cues convey living data without overwhelming the user.
Myrcene Sedation Index
+18%
Improved nighttime regimen adherence.
Limonene Mood Band
+26%
Floor staff accuracy on mood pairings.
Pinene Focus Arc
-12%
Reduced cognitive haze complaints.
Optimization
84%
Projected terpene uplift
Budtender Suite
Tablet-first cannabis intelligence for Nevada dispensaries.
The Budtender Suite is a dedicated, shared-device interface for floor staff. It surfaces strain guidance, terpene explanations, and patient-friendly talking points without exposing backend controls or PHI.
In Phase 1, this section anchors pilots and training; the live tablet UI remains gated while we finalize video walkthrough assets for secure distribution.
Floor-ready workflows
Rapid strain lookup, terpene-centric guidance, and simple patient-facing narratives tailored to Nevada's regulatory context.
Coming Soon
Workflow demo
Secure training footage will stream here once the build is ready. Request a guided preview to receive the private link.
Knowledge Library
Evidence-Based Intelligence.
We don't just aggregate data; we validate it through peer-reviewed briefs and TK-aligned clinical evidence. Full archive access is provided on request to verified partners.
Knowledge Library
Cannabis Therapeutics (JAMA Review 2026)
Evidence gap across U.S. clinicians
Topic: Therapeutic use of cannabis and cannabinoids
Key insight: Only 33% of clinicians feel confident in cannabis knowledge while 86% are requesting structured education.
Our solution: NeuroBotanica’s tiered evidence engine (ChemPath™ + BioPath™) delivers clinician-ready packets with TK provenance.
Hsu M, et al. JAMA. 2026;335(4):345-359.
Knowledge Library
Psilocybin Analogs & Cellular Longevity
Emory University · Discover Magazine 2026
Topic: Psilocybin analogs and anti-aging outcomes
Key insight: Metabolized psilocin extended human cell lifespan by 50%+ and preserved telomeres in vitro.
Our solution: Our Compliant Analog Discovery workflow flags non-hallucinogenic variants for regulated therapeutic pipelines.
Source: Discover Magazine / Emory University research notes.